nasdaq – pharmaceutical daily

February 27, 2017 Off

Verona puts COPD candidate RPL544 in focus for 2017, NASDAQ in four months?

According to Verona Pharma’s CEO, Dr. Jan-Anders Karlsson, the highlights of 2016 were encouraging clinical data for RPL554, additional financing from “a very experienced syndicate” of investors, and further strengthening of the company’s Board and executive team.

December 15, 2016 Off

TiGenix raises $35.65M proceeds with NASDAQ IPO

By Dino Mustafić

A biopharmaceutical company TiGenix focused on allogeneic expanded stem cells, has raised $35.65 million gross proceeds from the sale of 2,300,000 American Depository…

October 19, 2016 Off

GW Pharmaceutical cancels trading shares on AIM on December 2, 1016, continues trading on NASDAQ

By Dino Mustafić

GW Pharmaceuticals plc has announced leaving AIM and canceling trading in London, to continue trading only on NASDAQ.

October 26, 2015 Off

Anavex joins NASDAQ

By Dino Mustafić

Anavex Life Sciences Corp., has announced it would be trading its common stock on the NASDAQ, an American/Canadian stock exchange, one…